|Bid||100.00 x 1300|
|Ask||120.00 x 900|
|Day's Range||114.16 - 115.39|
|52 Week Range||104.28 - 133.49|
|PE Ratio (TTM)||12.84|
|Earnings Date||Jul 25, 2018 - Jul 30, 2018|
|Forward Dividend & Yield||0.96 (0.90%)|
|1y Target Est||132.65|
WARSAW, Ind., May 21, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a call for applications for its second Connected Health Innovation Award. The Company is accepting applications from individuals, groups and organizations — including academia and industry — from all countries within Europe, the Middle East and Africa (EMEA) region.
NEW YORK, May 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amkor ...
WARSAW, Ind., May 7, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that it will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference at the Encore at the Wynn in Las Vegas, Nevada on Wednesday, May 16, at 9:20 a.m. Pacific Time. A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at http://investor.zimmerbiomet.com. The webcast will be archived for replay following the conference.
WARSAW, Ind., May 3, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Deutsche Bank 43rd Annual Health Care Conference at the InterContinental Hotel in Boston, Massachusetts on Tuesday, May 8, 2018. Zimmer Biomet will present at 11:20 a.m. Eastern Time.
Stephanie Link , managing director at Nuveen, which has $970 billion in assets under management, is buying the post-earnings dip. On the flip side, Link sold Bristol-Myers BMY since she believes it's no longer a takeout target. When looking for an attractive entry point for equities, buying after earnings reports can be a good bet since stocks sometimes pop -- or drop -- unfairly after releasing quarterly results.
WARSAW, Ind., April 30, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a partnership agreement with Faith In Practice, a Houston-based non-profit organization that provides surgical, medical, dental and educational programs in Guatemala. Under the partnership, Zimmer Biomet will donate instrument sets and provide implants for Faith In Practice to place in inventory with the goal of improving access to total knee arthroplasty procedures for patients in underserved communities. Through the partnership's model, Faith In Practice will utilize Zimmer Biomet implants at the Las Obras Hospital in Antigua and Hilario Galindo Hospital in San Felipe, Retalhuleu, Guatemala.
NEW YORK, NY / ACCESSWIRE / April 26, 2018 / Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 26, 2018 at 8:30 AM Eastern ...
The Warsaw, Indiana-based company said it had net income of 85 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.91 per share. The results exceeded Wall Street expectations. ...
- Net sales of $2.018 billion for the first quarter represent an increase of 2.3% over the prior year period, and a decrease of 1.5% on a constant currency basis - Diluted EPS for the first quarter were ...
Let's take a look at the factors that are likely to impact the earnings results of a few MedTech bigwigs within the broader Medical universe.
WARSAW, Ind., April 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an agreement with Oregon Surgical Institute, a new ambulatory surgery center (ASC) in Beaverton, Ore., to implement the Zimmer Biomet Signature Solutions Outpatient Program. Oregon Surgical Institute, a joint venture between Regent Surgical Health and West End Surgical, LLC, is designed specifically to treat complex cases and procedures focused on total joint replacement and spine disorders.
Clearance of the Persona Trabecular Metal Tibia Allows Zimmer Biomet to Provide a Fully Cementless Total Knee Solution WARSAW, Ind. , April 16, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and ...
Zimmer Biomet's (ZBH) dull Knee sales continue to bother due to slower pace of supply recovery and sales recapture of certain key brands.
WARSAW, Ind., April 2, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the completion of the first surgical case utilizing its Comprehensive® Augmented Baseplate, which received FDA clearance on January 3, 2018. The case was performed by John W. Sperling, M.D., an orthopaedic surgeon at Mayo Clinic, who specializes in shoulder surgery. The Comprehensive Augmented Baseplate complements the Company's Comprehensive® Reverse Shoulder System by offering an alternative to bone grafting and eccentric reaming for patients with glenoid defects undergoing shoulder reconstruction.
Results Demonstrate Clinical Superiority of Mobi-C Two-Level Cervical Total Disc Replacement Procedures Compared to Anterior Cervical Discectomy and Fusion WARSAW, Ind. , March 28, 2018 /PRNewswire/ -- Zimmer ...
WARSAW, Ind., March 26, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its participation in the U.S. Department of Energy's (DOE) Better Buildings, Better Plants program. Zimmer Biomet entered into the voluntary agreement with the DOE in January as part of the Company's ongoing efforts to reduce its carbon footprint at locations across the United States and Puerto Rico. In joining the Better Buildings, Better Plants program, the Company has committed to reduce energy intensity by 25 percent over the next 10 years.
WARSAW, Ind. , March 22, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter sales and earnings conference call will be broadcast over the Internet on ...
WARSAW, Ind. , March 19, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Coleman (Cole) N. Lannum has been appointed ...
The German general named on Friday to lead defence procurement reforms vowed to continue the course set by his predecessor, Katrin Suder, a former McKinsey consultant who won praise for boosting transparency and being frank with industry. Lieutenant General Benedikt Zimmer, now Suder's deputy, will take over as state secretary after Suder decided to step down, the ministry said in a statement. The announcement should calm concerns voiced by German weapons makers who had worried that they might face another shift in procurement policy, depending on who replaced Suder.
WARSAW, Ind., March 12, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2018. The cash dividend of $0.24 per share will be paid on or about April 30, 2018 to stockholders of record as of the close of business on March 29, 2018. Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.